EQ - Equillium, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
6.51
-0.02 (-0.31%)
At close: 4:00PM EST

6.51 0.00 (0.00%)
After hours: 4:42PM EST

Stock chart is not supported by your current browser
Previous Close6.53
Open6.65
Bid5.50 x 1000
Ask6.67 x 800
Day's Range5.91 - 6.87
52 Week Range5.50 - 19.69
Volume24,042
Avg. Volume44,329
Market Cap113.119M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.91
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.00
Trade prices are not sourced from all markets
  • GlobeNewswire8 days ago

    Equillium Granted U.S. FDA Orphan Drug Designations for EQ001 (itolizumab) for both the Prevention and Treatment of Acute Graft-Versus-Host Disease

    Equillium, Inc. (EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designations for EQ001 for both the prevention and treatment of acute graft-versus-host disease (aGVHD). The FDA’s Orphan Drug designation program provides incentives to companies developing therapeutics for the safe and effective treatment, diagnosis or prevention of rare diseases and disorders that affect fewer than 200,000 people in the United States.

  • Benzinga4 months ago

    Equillium's IPO: What You Need To Know

    Equillium is set to begin trading on the Nasdaq Global Market under the ticker symbol “EQ.” The Details Equillium will offer 4.6 million shares of common stock in a price range between $14 and $16 per ...

  • We're sorry this is all we were able to find about this topic.